These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

942 related items for PubMed ID: 15266473

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiplatelet therapy and anticoagulation in patients with hypertension.
    Griffin G.
    Am Fam Physician; 2005 Mar 01; 71(5):897-9. PubMed ID: 15768617
    [Abstract] [Full Text] [Related]

  • 4. Antiplatelet agents and anticoagulants for hypertension.
    Shantsila E, Kozieł-Siołkowska M, Lip GY.
    Cochrane Database Syst Rev; 2022 Jul 28; 7():CD003186. PubMed ID: 35900898
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E, Lip GY.
    Cochrane Database Syst Rev; 2016 Sep 15; 9(9):CD003333. PubMed ID: 27629776
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.
    Lip GY, Gibbs CR.
    Cochrane Database Syst Rev; 2001 Sep 15; (4):CD003333. PubMed ID: 11687189
    [Abstract] [Full Text] [Related]

  • 9. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY, Wrigley BJ, Pisters R.
    Cochrane Database Syst Rev; 2012 Jun 13; (6):CD003336. PubMed ID: 22696335
    [Abstract] [Full Text] [Related]

  • 10. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
    Lip GY, Gibbs CR.
    QJM; 2002 Jul 13; 95(7):461-8. PubMed ID: 12096151
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
    Bedenis R, Lethaby A, Maxwell H, Acosta S, Prins MH.
    Cochrane Database Syst Rev; 2015 Feb 19; 2015(2):CD000535. PubMed ID: 25695213
    [Abstract] [Full Text] [Related]

  • 13. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY, Shantsila E.
    Cochrane Database Syst Rev; 2014 Mar 28; 2014(3):CD003336. PubMed ID: 24683002
    [Abstract] [Full Text] [Related]

  • 14. Anticoagulation for heart failure in sinus rhythm.
    Lip GY, Gibbs CR.
    Cochrane Database Syst Rev; 2001 Mar 28; (4):CD003336. PubMed ID: 11687190
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
    Robertson L, Ghouri MA, Kovacs F.
    Cochrane Database Syst Rev; 2012 Aug 15; 2012(8):CD002071. PubMed ID: 22895926
    [Abstract] [Full Text] [Related]

  • 19. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A, de Schryver EL, van Gijn J, Kappelle LJ, Koudstaal PJ.
    Cochrane Database Syst Rev; 2001 Aug 15; (4):CD001342. PubMed ID: 11687110
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.